Your Comprehensive End-to-End Guide to Transforming the Clinical Development of Cell & Vaccine Based Neoantigen Therapies

The growth and comeback of the neoantigen space has resulted in an abundance of new data, innovative insights and valuable lessons learned on how to drive meaningful clinical responses, all of which will be shared at the 6th Neoantigen Based Therapies US Summit.

Exploring the potential of shared neoantigens vs. personalized neoantigens and optimizing the selection and identification of the best and most immunogenic neoantigens, the world’s leaders from the likes for BioNTech, Gritstone, Advaxis, Genocea, Treos Bio and many more will gather at the only 3-day summit focused on the exploding field of Neoantigen based Therapies.

Join over 100 experts to discuss what the optimal control, clinical and combination trial designs should look like, advances in accurate and robust validation assays, and explore how we can manufacture effectively and at scale both shared and personalized neoantigen based therapies.

Leave this meeting equipped with new collaborations across pharma, biotech and academia, and learn how to supercharge vaccine and cell immunotherapies for solid tumors and beyond.

To know more about 6th Annual Neoantigen Based Therapies US Summit 2021 please click here.